Bharat biotech in talks with multinational pharma giants to boost COVAXIN production: Report Medical Dialogues Team3 May 2021 9:44 AM GMTHyderabad: With a motive to expand Covaxin production globally, Bharat Biotech is currently in talks with multinational pharma giants over producing th...
After Serum Institute, Bharat Biotech reduces Covaxin price to Rs 400 for states ruchika30 April 2021 7:30 AM GMTNew Delhi: Bharat Biotech on Thursday announced a cut in the price of its COVID-19 vaccine ''Covaxin'' it plans to sell to the states to Rs 400 pe...
Plea asks to direct Serum Institute, Bharat Biotech sell vaccines at uniform rate of Rs 150 ruchika29 April 2021 4:30 AM GMTMumbai: A public interest litigation (PIL) has been filed in the Bombay High Court challenging the different rates for COVID-19 vaccines for the ...
Covishield, Covaxin effective against Indian strain of Covid-19, claims study ruchika28 April 2021 9:25 AM GMTNew Delhi: Covishield and Covaxin -- the two coronavirus vaccines currently in use in India -- have efficacy against the 'Indian strain' and show 'mild...
Central Govt asks Bharat Biotech, Serum Institute to lower COVID vaccine prices ruchika27 April 2021 9:58 AM GMTNew Delhi: The central government on Monday asked the Serum Institute and Bharat Biotech to lower prices of their Covid-19 vaccines amid criticism from...
COVID Vaccination in India- Developments and Controversies Medical Dialogues Team26 April 2021 2:38 PM GMTNew Delhi: Engulfed by a calamitous coronavirus wave, the Government rolled out anti-COVID vaccines for the immunization programme against the deadly ...
Bharat Biotech seeks DCGI nod for extension of Covaxin shelf life from 6 to 24 months ruchika26 April 2021 7:18 AM GMTNew Delhi: Bharat Biotech has written to India's drug regulator seeking extension of the shelf-life of its indigenously developed Covid-19 vaccine Cova...
Bharat Biotech Covaxin shows 78 percent overall interim efficacy, 100 percent efficacy against severe Covid ruchika22 April 2021 6:00 AM GMTHyderabad: Drugmaker, Bharat Biotech, has recently announced phase 3 interim analysis results of COVAXIN. The second interim analysis is based on...
Bharat Biotech to expand Covaxin production capacity to 700 million doses annually ruchika21 April 2021 5:00 AM GMTHyderabad: Bharat Biotech recently announced that it has scaled up its COVID-19 vaccine Covaxin manufacturing capacity to 700 million doses per an...
Serum Institute, Bharat Biotech to get Rs 45.67 billion to boost Covid-19 vaccine production capacity ruchika20 April 2021 5:00 AM GMTNew Delhi: India's government has approved a 45.67-billion-rupee ($610 million) grant for COVID-19 vaccine makers Serum Institute of India (SII) and Bh...
Remdesivir production being doubled to 74.1 lakh per month by May: Dr Harsh Vardhan ruchika19 April 2021 7:09 AM GMTNew Delhi: Union Health Minister Harsh Vardhan on Sunday said there will be a 10 times rise in Covaxin vaccine production by September while manufactur...
Haffkine Institute secures Govt nod to manufacture Covaxin ruchika16 April 2021 10:12 AM GMTMumbai: The Union government has given its permission to the city-based Haffkin Institute to manufacture Covaxin, an anti-coronavirus vaccine of Bharat...
